PCI Medical, Inc. – Trademark Portfolio
Entity Type: 03
PCI Medical, Inc. owns a portfolio of 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GUS, ASTRA, OXID OUT, ASTRA TEE, and GLUTE OUT. Of these, 5 are registered. The portfolio spans 6 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 3 (Cosmetics & Cleaning). Headquartered in Phoenix, AZ.
1430 North 29th Avenue
Phoenix, AZ 85004
Showing of trademarks Trademarks
Trademark Classifications
PCI Medical, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PCI Medical, Inc. have?
PCI Medical, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 5 cancelled.
What trademark classes does PCI Medical, Inc. file in?
PCI Medical, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning), Class 9 (Computers & Electronics), Class 37 (Building & Construction), Class 20 (Furniture). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are PCI Medical, Inc.'s most well-known trademarks?
PCI Medical, Inc.'s registered trademark portfolio includes well-known marks such as GUS, ASTRA, OXID OUT, ASTRA TEE, and GLUTE OUT. These are among 5 currently registered trademarks in the portfolio.
What is PCI Medical, Inc.'s trademark registration success rate?
PCI Medical, Inc. has a 42% trademark registration rate, with 5 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.